Personalized Medicine and Biomarkers
The concept of personalized medicine is gaining traction in the Anti-VEGF Market. Researchers are working to identify biomarkers and genetic factors that can predict a patient's response to a particular anti-VEGF drug. This would allow doctors to select the most effective therapy for each individual patient from the outset, avoiding the time and cost associated with a trial-and-error approach.
Personalized medicine approaches are also crucial for managing anti-VEGF resistance, a phenomenon where some patients do not respond to or stop responding to a particular drug. By understanding the underlying reasons for this resistance, new and more targeted therapies can be developed. This shift towards a more personalized and precise approach to treatment is a key driver of innovation in the market.